The news directly pertains to Cigna Group as Cantor Fitzgerald has maintained a Neutral rating on the company and raised the price target. This suggests that the analyst sees potential in the company's stock but also acknowledges the risks involved. This could lead to a neutral impact on the stock's price in the short term.